Allworth Monetary LP boosted its stake in CVS Well being Co. (NYSE:CVS – Free Report) by 10.7% in the course of the third quarter, in accordance with the corporate in its most up-to-date submitting with the Securities and Trade Fee. The agency owned 17,613 shares of the pharmacy operator’s inventory after shopping for a further 1,706 shares in the course of the interval. Allworth Monetary LP’s holdings in CVS Well being had been value $1,108,000 on the finish of the latest quarter.
A number of different institutional buyers and hedge funds have additionally not too long ago purchased and bought shares of CVS. Capital World Buyers elevated its stake in CVS Well being by 8.0% in the course of the first quarter. Capital World Buyers now owns 43,776,874 shares of the pharmacy operator’s inventory value $3,491,643,000 after buying a further 3,232,172 shares in the course of the interval. Capital Worldwide Buyers elevated its stake in CVS Well being by 12.5% in the course of the first quarter. Capital Worldwide Buyers now owns 37,917,923 shares of the pharmacy operator’s inventory value $3,024,334,000 after buying a further 4,226,225 shares in the course of the interval. Capital Analysis International Buyers elevated its stake in CVS Well being by 1.4% in the course of the first quarter. Capital Analysis International Buyers now owns 13,143,822 shares of the pharmacy operator’s inventory value $1,048,351,000 after buying a further 184,297 shares in the course of the interval. Pzena Funding Administration LLC elevated its stake in CVS Well being by 132.9% in the course of the second quarter. Pzena Funding Administration LLC now owns 12,936,388 shares of the pharmacy operator’s inventory value $764,023,000 after buying a further 7,382,931 shares in the course of the interval. Lastly, Lazard Asset Administration LLC elevated its stake in CVS Well being by 5.9% in the course of the first quarter. Lazard Asset Administration LLC now owns 6,963,508 shares of the pharmacy operator’s inventory value $555,406,000 after buying a further 389,166 shares in the course of the interval. 80.66% of the inventory is at present owned by hedge funds and different institutional buyers.
CVS Well being Buying and selling Up 1.5 %
NYSE:CVS opened at $57.36 on Tuesday. The inventory has a fifty day transferring common value of $59.79 and a two-hundred day transferring common value of $59.76. The inventory has a market capitalization of $72.01 billion, a price-to-earnings ratio of 10.08, a PEG ratio of 0.84 and a beta of 0.54. The corporate has a debt-to-equity ratio of 0.83, a fast ratio of 0.66 and a present ratio of 0.86. CVS Well being Co. has a 1 yr low of $52.77 and a 1 yr excessive of $83.25.
CVS Well being (NYSE:CVS – Get Free Report) final introduced its quarterly earnings outcomes on Wednesday, August seventh. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Well being had a return on fairness of 12.72% and a web margin of 1.98%. The enterprise had income of $91.23 billion in the course of the quarter, in comparison with analysts’ expectations of $91.41 billion. Throughout the identical quarter final yr, the enterprise posted $2.21 earnings per share. The enterprise’s income for the quarter was up 2.6% on a year-over-year foundation. As a gaggle, sell-side analysts anticipate that CVS Well being Co. will publish 6.41 earnings per share for the present fiscal yr.
CVS Well being Publicizes Dividend
The enterprise additionally not too long ago disclosed a quarterly dividend, which shall be paid on Friday, November 1st. Buyers of document on Monday, October twenty first shall be paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized foundation and a dividend yield of 4.64%. The ex-dividend date of this dividend is Monday, October twenty first. CVS Well being’s payout ratio is at present 46.75%.
Analyst Scores Adjustments
CVS has been the subject of a lot of current analysis experiences. Mizuho lower their value goal on shares of CVS Well being from $73.00 to $66.00 and set an “outperform” ranking on the inventory in a analysis notice on Thursday, October twenty fourth. Cantor Fitzgerald restated a “impartial” ranking and set a $62.00 goal value on shares of CVS Well being in a analysis notice on Tuesday, October 1st. Truist Monetary upped their goal value on shares of CVS Well being from $66.00 to $76.00 and gave the inventory a “purchase” ranking in a analysis notice on Friday, October eleventh. TD Cowen upgraded shares of CVS Well being from a “maintain” ranking to a “purchase” ranking and upped their goal value for the inventory from $59.00 to $85.00 in a analysis notice on Friday, October 4th. Lastly, Royal Financial institution of Canada restated an “outperform” ranking and set a $68.00 goal value on shares of CVS Well being in a analysis notice on Wednesday, September 4th. 9 analysts have rated the inventory with a maintain ranking and 13 have assigned a purchase ranking to the corporate’s inventory. Based mostly on knowledge from MarketBeat, the corporate presently has a consensus ranking of “Reasonable Purchase” and a consensus value goal of $74.58.
Get Our Newest Evaluation on CVS Well being
About CVS Well being
CVS Well being Company gives well being options in america. It operates by Well being Care Advantages, Well being Companies, and Pharmacy & Client Wellness segments. The Well being Care Advantages section gives conventional, voluntary, and consumer-directed medical insurance merchandise and associated providers.
Really useful Tales
Obtain Information & Scores for CVS Well being Day by day – Enter your e-mail tackle under to obtain a concise day by day abstract of the newest information and analysts’ rankings for CVS Well being and associated firms with MarketBeat.com’s FREE day by day e-mail e-newsletter.
